✦ LIBER ✦

Safety and pharmacokinetics of a human monoclonal antibody to rabies virus: A randomized, dose-escalation phase 1 study in adults

✍ Scribed by Nithya Gogtay; Urmila Thatte; Nilima Kshirsagar; Brett Leav; Deborah Molrine; Peter Cheslock; Subhash V. Kapre; Prasad S. Kulkarni

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Open-label, dose escalation phase I stud

✍ Claribel P. Taylor; Sanjeev Tummala; Deborah Molrine; Lisa Davidson; Richard J. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 202 KB

377 A phase 1, dose-escalation, safety,

✍ Y. Bang; R. Cohen; T. Blumenkopf; Y. Zhang; M. Toh; A. Countouriotis; D. Shalins 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Safety and tolerability of chikungunya v

✍ Chang, Lee-Jah; Dowd, Kimberly A; Mendoza, Floreliz H; Saunders, Jamie G; Sitar, 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 254 KB

Two first-in-human, open-label, phase I

✍ Barbara White; Francisco Leon; Wendy White; Gabriel Robbie 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 149 KB

T1145 A Double-Blind, Placebo-Controlled

✍ Yellin, Michael; Goldwater, Ronald; Blanset, Diann L.; Cardarelli, Pina M. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 167 KB

A randomized dose-escalation study to as

✍ Yoichiro Ogama, Tomoko Mineyama, Asuka Yamamoto… 📂 Article 📅 2013 🏛 Carden Jennings Publishing 🌐 English ⚖ 360 KB